MYX vs VIT

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

MYX

M PHARMA FPO [MYX]

51MEDIUM

VIT

VITURA FPO [VIT]

49LOW

Score Breakdown

MYX VIT
Technical
51
53
Catalyst
53
51
Sentiment
50
50
Fundamental
85
76
Momentum
38
28
Risk Gate
42
45

Key Metrics

MYX Metric VIT
$233.2MMarket Cap$18.6M
291KAvg Volume (20d)682K
+2.5%Short InterestN/A
$6.50052-Week High$0.075
$2.04052-Week Low$0.021
-0.7%Daily Change+3.6%
$2.810Reference Price$0.029
-20.6%ROE+1.2%
-20.4%Profit Margin+0.6%

Active Signals

MYX Signals

●Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.6x)
●EPS estimates revised upward (+10pts)
●Near 52-week low (19% of range)
●CANSLIM I: Institutional ownership (36%)
●Deeply negative margins (-20%)

VIT Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.1x)
●Moderate revenue growth (+8%)
●Near 52-week low (13% of range)
●Micro-cap ($5-20M) - high risk

Ask Scout AI to compare MYX and VIT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

NAN vs NUZ →NAN vs PCK →NAN vs PEB →NAN vs PKY →NAN vs PTX →
MYX Full Analysis → VIT Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).